Reversal of Neuromuscular Blockade and Perioperative Arrhythmias - Trial NCT04720573
Access comprehensive clinical trial information for NCT04720573 through Pure Global AI's free database. This phase not specified trial is sponsored by Basaksehir Cam & Sakura ลehir Hospital and is currently Completed. The study focuses on Neuromuscular Blockade. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Basaksehir Cam & Sakura ลehir Hospital
Timeline & Enrollment
N/A
Jun 01, 2019
Nov 01, 2019
Primary Outcome
Significant arrhythmic event
Summary
Patients scheduled for elective abdominopelvic laparoscopic surgery under general anesthesia
 were included. Rocuronium was used for the neuromuscular blockade (NMB) and the level of NMB
 was monitored with train-of-four (TOF) measurements. The participants from whom informed
 consent had been received were allocated to two groups according to the agent used for
 reversal of NMB, sugammadex, or neostigmine. The ECG recordings of the subjects were followed
 with a rhythm Holter device throughout the procedure until the postoperative 12th hour.
 Additionally, preoperative and immediate postoperative 12-lead ECGs were evaluated for
 corrected QT calculations and QT dispersion. Proarrhythmogenicity was assessed with QT
 related measurements. The documented arrhythmic events on the Holter monitoring were
 designated as clinical end-points.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04720573
Non-Device Trial